Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bb66d9373d09efad73c142762f6dfb00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4745 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-008 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0073 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0043 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-124 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137 |
filingDate |
2007-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2012-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3bb282aea266fd924b6c6779c92210ac http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6125eddf675d1d119734da5562918a0d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ec84bd0c17ff42a5b2582acf4e188b1 |
publicationDate |
2012-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
AU-2007213819-B2 |
titleOfInvention |
Pharmaceutical formulation for aerosols, comprising two or more active agents and at least one surfactant |
abstract |
The invention relates to novel pharmaceutical formulations for aerosols, comprising at least two or more active agents and at least one surfactant and suitable for inhalative or nasal application. The invention particularly relates to pharmaceutical preparations for propellant-containing dosage aerosols containing a fluorohydrocarbon (HFA) as propellant, said preparations containing an active agent combination of at least two or more active agents, wherein at least one active agent is present in dissolved form and at least another active agent is present in the form of suspended particles in conjunction with at least one surfactant. |
priorityDate |
2006-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |